Richard G Ghalie, MEI Pharma's Chief Medical Officer, just received 320,000 options from the company. The strike price of the options received was $2.95, and these expire on July 01, 2031. Ghalie now owns at least 320,000 options on the company.
Some additional info was provided as follows:
One-quarter of such options shall vest on July 1, 2022, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022.
All options are currently exercisable.
One-quarter of such options vested on July 7, 2018, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 7, 2018.
One-quarter of such options vested on July 12, 2019, and the remaining three-quar
ters of such options shall vest monthly over a three-year period beginning on July 12, 2019.
One-quarter of such options vested on July 1, 2020, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020.
One-quarter of such options vested on July 2, 2021, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021.
One-quarter of such options shall vest on May 3, 2022, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on May 3, 2022.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever MEI Pharma makes a similar move, sign up!
